Resultados: 45

    Therapeutics and COVID-19: living guideline - 16 September 2022

    The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...

    COVID-19 rapid guideline: managing COVID-19. Last updated: 14 July 2022

    This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...

    Preterm labour and birth

    This guideline covers the care of women at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth. In this ...

    Diretrizes Brasileiras para o tratamento farmacológico de pacientes hospitalizados com COVID-19: Diretriz conjunta da Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia e Sociedade Brasileira de Reumatologia

    Há diversas terapias sendo utilizadas ou propostas para a COVID-19, muitas carecendo de apropriada avaliação de efetividade e segurança. O propósito deste documento é elaborar recomendações para subsidiar decisões sobre o tratamento farmacológico de pacientes hospitalizados com COVID-19 no Bras...

    Guía de práctica clínica basada en la evidencia para el abordaje del paciente adulto crítico con COVID-19: versión completa

    La presente guía de práctica clínica es un esfuerzo realizado por profesionales del Sistema Integrado de Salud (SNIS) coordinado por el Instituto Nacional de Salud (INS) ante la amenaza de la COVID-19 considerada una infección potencialmente mortal causada por el virus SARS-Cov2 y que actualmente rep...

    Guía práctica clínica para el manejo de COVID-19 en niños

    El tratamiento oportuno de personas con COVID-19 busca minimizar el número de complicaciones y muertes por esta enfermedad. Por ello, el Seguro Social de Salud del Perú (EsSalud) priorizó la realización de la presente guía de práctica clínica (GPC) con la finalidad de establecer recomendaciones ba...

    Guía de práctica clínica para el diagnóstico y manejo inicial de artritis reumatoide en el Seguro Social del Perú (EsSalud)

    La Artritis Reumatoide (AR) tiene adversas consecuencias en la salud su diagnóstico temprano y manejo óptimo requiere recomendaciones basadas en evidencia de alta calidad adaptadas a cada sistema de salud. Objetivo: Proveer recomendaciones clínicas basadas en evidencia para el diagnóstico y manejo in...

    Guía de práctica clínica basada en la evidencia para el manejo de trombocitopenia inmune primaria en población pediátrica

    Rev. Fac. Med. (Bogotá); 69 (3), 2021
    Primary immune thrombocytopenia (ITP) is the most common cause of thrombocytopenia in children, with a reported incidence of 1.1-12.5 cases per 100 000 children. However, currently, there are several definitions of ITP, as well as diagnostic and therapeutic approaches. To develop an evidence-based clinic...

    Bronchiolitis in children: diagnosis and management: Last updated 9 August 2021

    This guideline covers diagnosing and managing bronchiolitis in babies and children. It aims to help healthcare professionals diagnose bronchiolitis and identify if babies and children should be cared for at home or in hospital. It describes treatments and interventions that can be used to help with the s...

    Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report [Pré-print]

    The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved panelists developed key questions regarding the diagnosis o...